Evidence from genetic studies among rs2107538 variant in the CCL5 gene and Saudi patients diagnosed with type 2 diabetes mellitus

被引:7
作者
Alshammary, Amal F. [1 ]
Alshammari, Abdulrahman M. [2 ]
Alsobaie, Sarah F. [1 ]
Alageel, Arwa A. [1 ]
Khan, Imran Ali [1 ]
机构
[1] King Saud Univ, Coll Appl Med Sci, Clin Lab Sci Dept, Riyadh, Saudi Arabia
[2] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia
关键词
Type 2 Diabetes Mellitus; CCL5; gene; Rs2107538; variant; Saudi Population; POLYMORPHISMS; RANTES; RISK; ASSOCIATION; PROFILE; ARABIA; ASTHMA;
D O I
10.1016/j.sjbs.2023.103658
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Type 2 diabetes mellitus (T2DM) is a chronic and metabolic disorder that affects the adult population. Chemokines are proinflammatory cytokines that play a role in the development of chronic diseases such as obesity, gestational diabetes, and T2DM. The C-C Motif Chemokine Ligand 5 (CCL5) gene plays a role in antiviral immunity, tumor development, obesity, impaired glucose tolerance, and T2DM. This study aimed to investigate the genetic role of the rs2107538 variant in the CCL5 gene in Saudi patients with T2DM. Sixty subjects with T2DM patients and 60 healthy controls participated in this prospective case-control study. Prior to Sanger sequencing, genomic DNA was extracted and amplified with Polymerase chain reaction (PCR), after which the PCR products were purified. The collected data were used to conduct various statistical analyses to determine the relationship between T2DM and control subjects. The findings of the current study revealed a positive association for most parameters between T2DM and control subjects (p < 0.05). The frequency of genotypes (p = 0.002, AA vs.GG: p = 0.008, GA + AA vs. GG: p = 0.0002) and alleles (A vs. G: p = 0.0007) revealed a strong risk association. Multiple logistic regression with individual effects revealed a link between SBP and HDLc levels (p = 0.03). In patients with T2DM, waist (p = 0.001), TG (p = 0.0007), and LDLc (p = 0.0004) levels were all associated with the ANOVA. Finally, the rs2107538 variant was linked to an increased risk of T2DM in the Saudi Population. The GA and AA genotypes were strongly connected to the T2DM subjects. In order to rule out disease-causing variants in the global population, future research should use a large sample size. (c) 2023 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:8
相关论文
共 38 条
  • [1] Alshammari M H., 2021, Open Journal of Epidemiology, V11, P113, DOI [10.4236/ojepi.2021.112011, DOI 10.4236/OJEPI.2021.112011]
  • [2] Annis Ann M, 2005, Prev Chronic Dis, V2, pA19
  • [3] SUSPECTED SYNERGISM BETWEEN CONSANGUINITY AND FAMILIAL AGGREGATION IN TYPE-2 DIABETES-MELLITUS IN SAUDI-ARABIA
    ANOKUTE, CC
    [J]. JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1992, 112 (04): : 167 - 169
  • [4] Molecular Genetics of Abnormal Redox Homeostasis in Type 2 Diabetes Mellitus
    Azarova, Iuliia
    Polonikov, Alexey
    Klyosova, Elena
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [5] Biadgo B, 2017, ETHIOP J HEALTH SCI, V27, P215, DOI 10.4314/ejhs.v27i3.3
  • [6] RANTES gene polymorphisms redict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients
    Böger, CA
    Fischereder, M
    Deinzer, M
    Aslanidis, C
    Schmitz, G
    Stubanus, M
    Banas, B
    Krüger, B
    Riegger, GAJ
    Krämer, BK
    [J]. ATHEROSCLEROSIS, 2005, 183 (01) : 121 - 129
  • [7] Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review
    Colosia, Ann D.
    Palencia, Roberto
    Khan, Shahnaz
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 327 - 338
  • [8] Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma
    Duell, EJ
    Casella, DP
    Burk, RD
    Kelsey, KT
    Holly, EA
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (04) : 726 - 731
  • [9] Elhadd TA, 2007, ANN SAUDI MED, V27, P241
  • [10] Herder C., 2008, EUR J ENDOCRINOL